Results 31 to 40 of about 6,255,411 (296)

Preventing Chronic Disease [PDF]

Preventing Chronic Disease (PCD) had its most successful year to date in 2021. Despite the challenges of working during the pandemic, PCD published 4 important collections, published the most widely read article in its history, and continued to appoint ...

core   +3 more sources

Estrogen Receptors and Chronic Venous Disease [PDF]

European Journal of Vascular and Endovascular Surgery, 2016
Chronic venous disease (CVD) is a common and relevant problem affecting Western people. The role of estrogens and their receptors in the venous wall seems to support the major prevalence of CVD in women. The effects of the estrogens are mediated by three estrogen receptors (ERs): ERα, ERβ, and G protein-coupled ER (GPER).
Serra R., Gallelli L., Perri P., De Francesco E. M., Rigiracciolo D. C., Mastroroberto P., Maggiolini M., De Franciscis S.   +7 more
openaire   +6 more sources

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source

Fixed-dose combinations in pharmacotherapy of chronic venous diseases

Амбулаторная хирургия
Chronic venous diseases are the most common vascular diseases of the lower extremities, negatively affecting all components of the quality of life in the modern society.
V. Yu. Bogachev, B. V. Boldin, K. V. Komov, O. V. Dzhenina   +3 more
doaj   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source

Burden and Suffering in Chronic Venous Disease [PDF]

Advances in Therapy, 2019
Chronic venous disease (CVD) is widespread, underdiagnosed, and can progress to chronic venous insufficiency and venous ulcers, which can require extensive treatment and hospitalization. These conditions negatively impact patient quality of life and place substantial burdens on healthcare resources. The two main risk factors for CVD are age and obesity.
Nicolaides, Andrew N., Labropoulos, Nicos   +1 more
openaire   +2 more sources

Liver organoids: modelling complexity in homeostasis and disease

FEBS Letters, EarlyView.
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley   +1 more source

Revisiting Heinz-Lippman disease as a complication of chronic venous insufficiency

Journal of Vascular Surgery Cases and Innovative Techniques
Chronic venous insufficiency with and without ulceration is a common complication of varicose veins. Heinz-Lippmann disease is a potentially underreported complication of chronic venous insufficiency that involves heterotopic ossification of the peri ...
Alisha Oropallo, MD, FACS, Amanda Beneat, MD, Amit Rao, MD, Eric Goodman, MD   +3 more
doaj   +1 more source

Identifying symptoms in chronic venous diseases

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2016
Dear Editors, We have read the article published by Hansrani et al. [1] with great interest. In their well defined case control study, they have evaluated the venous symptoms in patients with pelvic vein incompetence (PVI) and varicose veins (VV). They have recruited 40 premenopausal women with PVI and VV, 40 premenopausal women only with VV and 40 ...
Öztürk, Selçuk, Yetkin, Ertan
openaire   +2 more sources

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source